U.S. Capital Markets Stock News

AMERISAFE (AMSF) has wrapped up FY 2025 with fourth quarter total revenue of US$81.6 million and basic EPS of US$0.55, alongside net income of US$10.4 million, putting a clear spotlight on how its workers’ compensation book is translating into bottom line results. The company has seen trailing twelve month revenue sit at US$317.3 million with EPS of US$2.48 and net income of US$47.1 million, giving investors a fuller view of how the latest quarter fits into the broader earnings trend. With...

Trip.com Group (NasdaqGS:TCOM) closed out FY 2025 with fourth quarter revenue of C¥15.4b and basic EPS of C¥6.53, while trailing twelve month figures showed revenue of C¥62.4b and EPS of C¥50.62, anchoring the latest print against a much stronger full year base. Over the past few quarters, the company has seen revenue move from C¥14.8b in Q2 2025 and C¥18.3b in Q3 2025 to C¥15.4b in Q4 2025. Quarterly EPS ranged from C¥6.48 in Q1 2025 to C¥30.36 in Q3 2025 and C¥6.53 in Q4 2025, giving...

Zevia PBC (ZVIA) just wrapped up FY 2025 with Q4 revenue of US$37.9 million and a basic EPS loss of US$0.02, alongside a trailing twelve month loss of US$9.9 million on revenue of US$161.3 million. Over recent quarters, the company has seen quarterly revenue move between US$36.4 million and US$44.5 million, while basic EPS losses have ranged from US$0.01 to US$0.10 per share. Together, these figures present a picture of relatively steady sales but still negative earnings. For investors, the...

Option Care Health reported strong 2025 results, with significant revenue growth and expanded service offerings across its infusion network. The company increased its footprint of infusion suites and invested in automation and AI to support operational efficiency. Management highlighted disciplined capital allocation, including targeted M&A, while managing headwinds from biosimilar conversions and reimbursement pressures. Option Care Health (NasdaqGS:OPCH) is coming off a year of solid...

EVA Live (Nasdaq:GOAI) has launched Fast Quote Direct™, an AI-powered quoting engine designed to automate online lead qualification across financial services, insurance, home services, and other industries.

Simmons First National (SFNC) closed out FY 2025 with fourth quarter revenue of US$233.9 million and basic EPS of US$0.54, following a turbulent year in which trailing twelve month figures show revenue of US$37.4 million and a basic EPS loss of US$2.96. Over recent quarters, the company has seen quarterly revenue move from US$162.7 million in Q3 2024 to US$195.2 million in Q4 2024, then to US$182.8 million, US$202.2 million and US$233.9 million through Q1 to Q4 2025. Basic EPS shifted from...

Sarepta Therapeutics (SRPT) closed out FY 2025 with Q4 revenue of US$442.9 million and a basic EPS loss of US$3.93, alongside a full year trailing net loss of US$713.4 million on US$2.2 billion of revenue. Over the last six quarters in the data, revenue has ranged from US$399.4 million to US$744.9 million per quarter. Basic EPS has swung between a profit of US$2.01 and a loss of US$4.60, highlighting sharp shifts in margins that keep profitability firmly in focus for investors. See our full...

Rumble Shorts has been approved on Google Play, bringing the company’s short form video product to Android users. The launch broadens access to Rumble’s content platform and extends its presence within a major mobile ecosystem. For investors watching NasdaqGM:RUM, the rollout of Rumble Shorts on Google Play adds a new layer to the company’s product mix at a time when short form video remains a core format for online viewing. Shares most recently closed at $5.76, with the stock showing a 1...

Ameren Missouri, a subsidiary of Ameren Corporation, has priced a new public offering of first mortgage bonds. The company plans to use the proceeds to refinance existing debt and fund near term capital expenditures. This financing step is intended to reshape Ameren Missouri's debt profile and support upcoming investment needs. For investors watching Ameren (NYSE: AEE), this bond move sits alongside a share price of $111.44 and multi year returns. The stock is up 2.9% over the past week,...

Tronox Holdings (NYSE:TROX) is expanding further into the rare earth supply chain, signaling a push beyond its traditional titanium dioxide business. The company has filed a universal shelf registration, giving it flexibility to raise capital through a range of securities if and when it chooses. At a share price of $7.2, NYSE:TROX has had a mixed return profile, with a 68.6% gain year to date alongside a 46.9% decline over 3 years and a 52.5% decline over 5 years. Over the past month the...

DMC Global Inc. has reported its fourth-quarter 2025 results, with sales falling to US$143.53 million from US$152.37 million a year earlier and swinging from a small net income to a net loss of US$11.16 million. For full-year 2025, the company reduced its net loss to US$13.45 million despite lower sales of US$609.84 million, but management’s first-quarter 2026 guidance flags continued operational pressures and weather-related disruptions that are expected to weigh on near-term...

If you are wondering whether Intapp is starting to look interesting at its current share price, you are not alone and this article is designed to help you weigh that up. The stock has recently seen a 5.2% decline over the last week, a 44.9% decline over the last month and a 67.3% decline over the past year, which will naturally raise questions about both risk and potential future returns. These moves sit against a backdrop of ongoing coverage of Intapp as a listed software company, with...

If you are wondering whether nCino is starting to look attractively priced or just risky after a rough stretch, this article walks through what the current share price might be telling you. The stock last closed at US$15.81, with returns of 3.3% decline over 7 days, 35.4% decline over 30 days, 35.9% decline year to date, 49.2% decline over 1 year and 40.5% decline over 3 years, while the 5 year return sits at 76.7% decline. Recent news around nCino has focused on its role as a cloud banking...

Nomad Foods (NYSE:NOMD) has set a shareholder capital return plan for 2025 that lifts dividends and share repurchases by 38% year on year. The company is also preparing broad organizational and planning changes for 2026 aimed at performance and value creation. This combination of higher cash returns and a reset year ahead marks a clear shift in how Nomad Foods is approaching capital allocation and its business setup. For investors looking at the frozen foods group today, Nomad Foods trades...

General American Investors Company, Inc. has reported its full-year 2025 results, posting revenue of US$24.31 million and net income of US$339.84 million for the year ended December 31, 2025. The contrast between relatively modest revenue and very large net income highlights how investment gains can significantly shape this closed-end fund’s financial profile. With this unusually wide gap between revenue and net income, we’ll explore what the latest earnings mean for General American...

If you are wondering whether Xometry's share price still makes sense after recent swings, you are not alone. This article is going to focus squarely on what you are really paying for in the business. The stock last closed at US$41.82, with a 7 day return of 27.4% decline, a 30 day return of 34.7% decline, a year to date return of 33.4% decline, a 1 year return of 54.8%, and a 3 year return of 127.3%. Recent coverage has highlighted Xometry's position as an online marketplace for...

Boise Cascade (NYSE:BCC) acquired Holden Humphrey, expanding its distribution presence in the US Northeast. The company opened a new Greenfield Distribution Center in Texas, adding capacity and reach for its Building Materials Distribution segment. Boise Cascade recorded a $6 million legal accrual related to a Lacey Act investigation tied to its distribution business. Boise Cascade is a wood products and building materials distributor that serves dealers, homebuilders, and industrial...

Vanda Pharmaceuticals (VNDA) is back on investors’ radar after the U.S. Food and Drug Administration approved BYSANTI tablets for bipolar I disorder and schizophrenia, while an earlier imsidolimab filing for generalized pustular psoriasis also progresses through review. See our latest analysis for Vanda Pharmaceuticals. The recent FDA approvals and filings have coincided with sharp share price moves, with a 37.31% 7 day share price return and 56.23% 90 day share price return, while the 1 year...

AXIS Capital Holdings (NYSE:AXS) announced the retirement of board member Thomas Ramey. His retirement represents a change in the company’s board-level governance structure. For you as an investor, board changes at an insurer like AXIS Capital Holdings matter because they sit close to decisions on risk appetite, capital allocation and long term priorities. The company operates in specialty insurance and reinsurance, areas that can be influenced by evolving regulation and changing views on...

Allison Transmission Holdings (ALSN) closed out FY 2025 with Q4 revenue of US$737 million and basic EPS of US$1.19, alongside net income of US$99 million that sets the tone for how investors read the full year. The company has seen quarterly revenue move from US$824 million in Q3 2024 to US$814 million in Q2 2025, US$693 million in Q3 2025 and then US$737 million in Q4 2025. Basic EPS shifted from US$2.30 to US$2.32, US$1.63 and US$1.19 over the same stretch, giving a clear read on how top...

If you are wondering whether M/I Homes is still good value after a strong multi year run, this article walks through how its current share price stacks up against several valuation measures. The stock closed at US$140.40 recently, with returns of 4.8% over 30 days, 9.8% year to date and 17.9% over 1 year. The 3 year return sits at a very large 138.7%, and the 5 year return at 180.7%. Recent coverage of M/I Homes has focused on its position within the U.S. homebuilding sector and how...

Over the past few years, Quanex Building Products has experienced a significant drop in operating margin, earnings per share, and return on invested capital despite continuing to grow its revenue base. This combination of rising costs and weaker profitability on a per‑share and invested‑capital basis points to mounting operational pressures and fewer attractive growth opportunities within the business. Next, we’ll examine how this sustained margin deterioration challenges Quanex’s earlier...

Illinois Tool Works (NYSE:ITW) has entered into a new US$3.0b five year revolving credit facility. The agreement replaces the company’s previous revolving credit facility more than a year before its scheduled expiry. The facility includes multi currency and rate options and can be increased to up to US$5b, subject to conditions. Illinois Tool Works, a diversified industrial manufacturer serving multiple end markets, now has a refreshed liquidity backstop that can support its ongoing...

If you are looking at Shoals Technologies Group and wondering whether the current share price reflects its true value, this article will walk you through what the numbers are saying in plain terms. The stock last closed at US$6.85, with returns of a 36.2% decline over 7 days, a 26.1% decline over 30 days, a 24.6% decline year to date, a 76.8% gain over 1 year, a 72.8% decline over 3 years and a 79.8% decline over 5 years, which gives a mixed picture of recent and longer term...